 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NexCura Websites: |
| NEWS: Thomson Healthcare online treatment tools mark milestone |
READ MORE > |
|
|
Patient Source
NexCura has a database of more than 700,000 patients with cancer, cardiovascular and respiratory diseases. Each week, more than 4,000 new patients register with our free, online decision-support tools to learn more about their conditions and to help them make better-informed treatment decisions.
NexCura hosts and maintains proprietary patient education tools – the NexProfiler™ Treatment Option Tools and the Heart Profiler® Treatment Option Tools using a patented technology that matches a patient with the inclusion criteria of the significant clinical research that serves as the basis for standard of care. These educational tools require registration, acceptance of NexCura's Terms and Conditions agreement and the option to receive e-mail messages and e-newsletters providing additional information about new treatments and services, clinical trials and market research opportunities.
Patients may sign up to use any of the 29 educational tools on hundreds of health information Web sites, notably including the American Cancer Society, American Heart Association and the American Lung Association.
To use our educational tools, a patient may complete an in-depth questionnaire that includes diagnosis, treatments undertaken, co-morbid conditions and test results. A patient's self-reported clinical parameters are then matched against a medical database that results in highly personalized reports detailing treatment options and, in some cases, the relevant medical literature on treatment options and outcomes specific to that patient.
NexCura uses the information that is provided by patients in their questionnaire, to specifically target e-mail messaging not only to the general disease category, but also within subgroups based on stage, severity, medications used, or comorbid conditions.
With our database, NexCura can create inclusion/exclusion query filters for each campaign to target highly specific, highly motivated patient populations who are interested in clinical trials, direct-to-patient marketing and market research.
|
|
